AstraZeneca Pharma gets DCGI nod to market asthma drug
NEW DELHI: Drug firm AstraZeneca Pharma on Monday said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma. AstraZeneca Pharma India Ltd has received import…
Maharashtra Directorate of Health Services ban Ranitidine use in govt hospitals until further notice
In India, over 180 products based on ranitidine are sold by various leading drug makers with market size of about Rs 750 crore. Ranitidine, an old molecule, is prescribed for intestinal…